According to Oryzon Genomics's latest financial reports and stock price the company's current Operating Margin is -31,330.20%. At the end of 2017 the company had an Operating Margin of -31,330.24%.
Year | Operating Margin | Change |
---|---|---|
2017 | -31,330.24% | 4104.05% |
2016 | -745.24% | 3219.48% |
2015 | -22.45% | -143.71% |
2014 | 51.36% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.